glp-1 drugs with fewest side effects Your guide to Balancing Benefits: Which GLP-1 Has

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Initially developed to improve glycemic control, these agents are now recognized as important components of cardiovascular risk reduction strategies

As California ends Medicaid coverage for GLP-1 weight loss drugs likeWegovy and Zepbound, experts say the states advice to simply eat better isnt realistic for many patients.

Learn what Toujeo actually is, how insulin glargine differs from GLP-1 agonists like semaglutide, and why the distinction matters.

Read more at straitstimes.com

The review urges nurse practitioners to balance expanding clinical promise with careful prescribing, patient education, monitoring, access advocacy, and vigilance for gastrointestinal, endocrine, pregnancy-related, and rare serious risks.